This advancement has potential for applications in treating "cancer immunotherapies and cell-based therapies for HIV, primary immune deficiencies, and autoimmune diseases."
Ovaj napredak ima potencijal za primenu u lečenju „immunoterapije raka i terapije na bazi ćelija za HIV, primarnog nedostatka imunosti i autoimunih bolesti“.